Novavax (NVAX) concluded the recent trading session at $6.41, signifying a +1.75% move from its prior day's close.

Shares of Novavax Inc. NVAX slid 7.68% to $6.49 Tuesday, on what proved to be an all-around poor trading session for the ...

This was the stock's second consecutive day of losses.

Wall Street’s major market averages seesawed back and forth on Friday and finished mixed as Federal Reserve Governor ...

Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Novavax Inc. closed 60.53% below its 52-week high of $17.81, which the company reached on July 26th.

Citi initiated coverage on small- and mid-cap biotechnology companies on early signs of improving sentiment in a sector weighed down this year by policy uncertainty and weak investor interest.

Novavax (NASDAQ:NVAX) shares fell on Tuesday after Citi started its coverage of the COVID shot maker with a Sell recommendation and a price target of $6, citing among other issues concerns over the ...

Meanwhile, broader market gains such as the S&P 500's upward trajectory and... Novavax, Inc. (Nasdaq: NVAX) today announced results of the initial cohort of its COVID-19-Influenza Combination (CIC ...

Novavax has experienced a notable decline in its stock price over the past week, dropping by 8.82%. This downturn comes amidst a challenging landscape for the company, as Citi ini ...